Methods for treating pemphigus disorders
US12403175B2 · kind B2 · utility
0Cited by
40References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2021 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/528
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for treating pemphigus using an FcRn antagonist such as efgartigimod. The methods of the invention provide a rapid onset of action to enable early disease control and maintenance of clinical remission, with or without a minimal dose of corticosteroids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.